Incidence of sarcopenia and physical disability in elderly patients in nursing practice

Jitka Doležalová, Jan Neugebauer, Valérie Tóthová
University of South Bohemia in České Budějovice, Faculty of Health and Social Sciences, Institute of Nursing, Midwifery and Emergency Care, České Budějovice, Czech Republic

Korespondenční autor: Jitka Doležalová (

ISSN 1804-7181 (On-line)

Full verze:
Full version

Submitted:29. 6. 2021
Accepted: 13. 12. 2021
Published online: 31. 12. 2021


Background: An overview of sarcopenia status assessment using assessment tools and other measurement techniques over the last 3 years.

Purpose: The main goal of the study is to survey the practical information on the incidence of sarcopenia and physical disability in the elderly population, and to analyze the available sarcopenia measurements in nursing practice.

Methods: Based on the determined conditions, 9 studies were selected that focus on the evaluation of sarcopenia.

Results: The results show that the evaluation criteria according to EWGSOP are the most frequently used for the diagnosis of sarcopenia. Based on the analysis of these studies, SARC.F became the most widely used assessment tool.

Conclusions: Sarcopenia is a serious disease that comes with age. It has been shown to cause disability in the elderly population. It is necessary to regularly treat sarcopenia and implement it more in nursing care.

Keywords: Disability; Geriatric (elderly) patient; Nursing and assessment; Sarcopenia


1. Anker SD, Morley JE, von Haehling S (2016). Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7(5): 512–514. DOI: 10.1002/jcsm.12147.

2. Aslam S, Emmanuel P (2010). A critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS 31(1): 47–50. DOI: 10.4103/0253–7184.69003.

3. Bahat G, Oren MM, Yilmaz O, Kiliç C, Aydin K, Karan MA (2018). Comparing SARC-F with SARCCalF to Screen Sarcopenia in Community Living Older Adults. J Nutr Health Aging 22(9): 1034– 1038. DOI: 10.1007/s12603–018–1072-y.

4. Breen L, Stoke s K, Churchward-Venne T, Moore D, Baker S, Smith K (2013). Two weeks of reduced activity decreases leg lean mass and induces “anabolic resistance” of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab 98(6): 2604–2612. DOI: 10.1210/jc.2013–1502.

5. Cawthon PM, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. (2020). Establishing the Link Between Lean Mass and Grip Strength Cut Points With Mobility Disability and Other Health Outcomes: Proceedings of the Sarcopenia Definition and Outcomes Consortium Conference. J Gerontol A Biol Sci Med Sci 75(7): 1317–1323. DOI: 10.1093/gerona/glz081.

6. Cesari M, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. (2012). Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle 3(3): 181–190. DOI: 10.1007/s13539–012–0078–2.

7. Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyan KS, et al. (2014). Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15(2): 95–101. DOI: 10.1016/j.jam­da.2013.11.025.

8. Confortin SC, Meneghini V, Ono LM, Schneider IJC, Barbosa AR, D’Orsi E (2017). Anthropometric indicators as a screening tool for sarcopenia in older adults from Florianópolis, Santa Catarina: EpiFloripa Ageing study. Rev Nutr 30(3): 287–296. DOI: 10.1590/1678–98652017000300002.

9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. (2010). Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39(4): 412–423. DOI: 10.1093/ageing/ afq034.

10. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1): 16–31. DOI: 10.1093/ ageing/afy169.

11. Czech Health Statistics Yearbook 2017 (2018). [Zdravotnická ročenka České republiky 2017]. Prague: Ústav zdravotnických informací a statistiky ČR (Czech).

12. da Silva Alexandre T, de Oliveira Duarte YA, Ferreira Santos JL, Wong R, Lebrão ML (2014). Sarcopenia according to the European Working Group on Sarcopenia in older people (EWGSOP) versus dynapenia as a risk factor for disability in the elderly. J Nutr Health Aging 18(5): 547–553. DOI: 10.1007/s12603–014–0465–9.

13. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. (2011). Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12: 249–256. DOI: 10.1016/j.jam­da.2011.01.003.

14. Flemr L, Němec J, Kudláčková K (Eds) (2014). Physical activity in science & practice: Conference Proceedings: in celebration of the 60th anniversary of the establishment of the faculty of physical education and sport, Charles University in Prague: Prague, 19–21 June 2013. Prague: Karolinum.

15. Fragala M, Dam T, Barber V, Judge J, Studenski S, Cawthon PM (2015). Strength and Function Response to Clinical Interventions of Older Women Categorized by Weakness and Low Lean Mass Using Classifications From the Foundation for the National Institute of Health Sarcopenia Project. J Gerontol A Biol Sci Med Sci 70: 202–209. DOI: 10.1093/gerona/glu110.

16. Gülpinar O, Güçal Güçlü A (2014). How to write a review article? Turk J Urol 39(1): 44–48. DOI: 10.5152/tud.2013­.054.

17. Howard C, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R, et al. (2007). Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol 103: 17–20. DOI: 10.1152/japplphy­siol.00133.2007.

18. Janssen I, Baumgartner N, Ross R, Rosenberg IH, Roubenoff R (2004). Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159(4): 413–421. DOI: 10.1093/aje/kwh058.

19. Jarošová D, Zeleníková R (2014). Ošetřovatelství založené na důkazech [Evidence Based Nursing]. Prague: Grada Publishing, 136 p. (Czech).

20. Jasemi M, Valizadeh L, Zamanzadeh V, Keogh B (2017). A concept analysis of holistic care by hybrid model. Indian J Palliat Care 23(1): 71–80. DOI: 10.4103/0973–1075.197960.

21. Johnson ML, Robinson MM, Nair KS (2013). Skeletal muscle aging and the mitochondria. Trends Endocrinol Metab 24: 247–256. DOI: 10.1016/j.tem­.2012.12.003.

22. Kera T, Kawai H, Hirano H, Kojima M, Watanabe Y, Motokawa K, et al. (2019). SARC-F: A validation study with community-dwelling older Japanese adults. Geriatr Gerontol Int 19(11): 1172–1178. DOI: 10.1111/ggi.13768.

23. Kim M, Won CW (2019). Prevalence of sarcopenia in community-dwelling older adults using the definition of the European Working Group on Sarcopenia in Older People 2: findings from the Korean frailty and aging cohort study. Age Ageing 48(6): 910–916. DOI: 10.1093/agein­g/afz091.

24. Kimber M, McTavish JR, Couturier J, Boven A, Gill S, Dimitropoulos G, et al. (2017). Consequences of child emotional abuse, emotional neglect and exposure to intimate partner violence for eating disorders: a systematic critical review. BMC Psychol 5(1): 33. DOI: 10.1186/s40359–017–0202–3.

25. Melnyk BM, Fineout-Overholt E, Stillwell SB, Williamson KM (2010). Evidence-based practice: step by step. Am J Nurs 110(1): 51–53. DOI: 10.1097/01.NAJ­.0000366056.06605­.d2.

26. MKN-10 (2009). Mezinárodní statistická klasifikace nemocí a přidružených zdravotních problémů, 10. revize: aktualizovaná druhá verze k 1. 1. 2009. [International Statististical Classification of Diseases and Related Health Problems, 10th revision: updated second version to 1. 1. 2009]. 2nd ed. Praha: Bomton Agency; 2008 (Czech).

27. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339: b2535. DOI: 10.1136/bmj. b2535.

28. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. (2011). Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 12(6): 403–409. DOI: 10.1016/j. jamda.2011.04.014.

29. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, et al. (2010). Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29: 154–159. DOI: 10.1016/j.clnu­.2009.12.004.

30. Nagai Y, Noguchi H (2002). How designers transform keywords into visual images. In: Proceedings of the fourth conference on creativity & cognition – C&C ‚02. New York, New York, USA: ACM Press, pp. 118–125. DOI: 10.1145/581710­.581729.

31. Nascimento CM, Ingles M, Salvador-Pascual A, Cominetti MR, Gomez-Cabrera MC, Viña J (2019). Sarcopenia, frailty and their prevention by exercise. Free Radic Biol Med 132: 42–49. DOI: 10.1016/j. freeradbiomed­.2018.08.035.

32. Newbert SL (2007). Empirical research on the resource-based view of the firm: an assessment and suggestions for future research. Strateg Manag J 28(2): 121–146. DOI: 10.1002/smj.573.

33. Park SS, Seo Y-K, Kwon K-S (2019). Sarcopenia targeting with autophagy mechanism by exercise. BMB Rep. 52(1): 64–69. DOI: 10.5483/BMBRep­.2019.52.1.292.

34. Pearce PF, Hicks RW, Pierson CA (2018). Keywords matter: A critical factor in getting published work discovered. J Am Assoc Nurse Pract 30(4): 179–181. DOI: 10.1097/JXX.00000000000­00048.

35. Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kässmann H, et al. (2019). Sarcopenia and osteoporosis are interrelated in geriatric inpatients. Z Gerontol Geriatr 52(7): 688–693. DOI: 10.1007/s00391–019–01553-z.

36. Rodriguez-Rejon AI, Artacho R, Puerta A, Zuñiga A, Ruiz-Lopez MD (2018). Diagnosis of sarcopenia in long-term care homes for the elderly: the sensitivity and specificity of two simplified algorithms with respect to the EWGSOP consensus. J Nutr Health Aging 22(7): 796–801. DOI: 10.1007/s12603– 018–1004-x.

37. Rosenberg I (1989). Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50: 1231–1233. DOI: 10.1093/ ajcn/50.5.1231.

38. Rygiel KA, Picard M, Turnbull DM (2016). The ageing neuromuscular system and sarcopenia: a mitochondrial perspective. J Physiol 594: 4499–4512. DOI: 10.1113/JP271212.

39. Sakuma K, Yamaguchi A (2012). Sarcopenia and age-related endocrine function. Int J Endocrinol 2012: 1–10. DOI: 10.1155/2012/1­27362.

40. Shen Y, Chen J, Chen X, Hou LS, Lin X, Yang M (2019). Prevalence and associated factors of sarcopenia in nursing home residents: A systematic review and meta-analysis. J Am Med Dir Assoc 20(1): 5–13. DOI: 10.1016/j.jam­da.2018.09.012.

41. Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, et al. (2018). Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition 55–56(04): 51–55. DOI: 10.1016/j.nut­.2018.03.046.

42. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. (2014). The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 69: 547–558. DOI: 10.1093/gerona/glu010.

43. Su Y, Hirayama K, Han T-F, Izutsu M, Yuki M (2019). Sarcopenia prevalence and risk factors among Japanese community dwelling older adults living in a snow-covered city according to EWGSOP2. J Clin Med 8(3): e291. DOI: 10.3390/jcm8030291.

44. Suhonen R, Charalambous A (2019). The concept of individualised care. Individualized care. Cham: Springer International Publishing, pp. 27–38. DOI: 10.1007/978–3–319–89899–5_4.

45. Toth MJ, Matthews DE, Tracy RP, Previs MJ (2005). Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation. Am J Physiol Endocrinol Metab 288: 883–891. DOI: 10.1152/ajpen­do.00353.2004.

46. Vellas B (2018). Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by international conference on frailty and sarcopenia research task force. J Frailty Aging 7(1): 2–9. DOI: 10.14283/jfa.2017­.30.

47. Walston JD (2012). Sarcopenia in older adults. Curr Opin Rheumatol 24(6): 623–627. DOI: 10.1097/ BOR.0b013e32835­8d59b.

48. Welch C, Hassan-Smith KZ, Greig CA, Lord JM, Jackson TA (2018). Acute sarcopenia secondary to hospitalisation – An emerging condition affecting older adults. Aging Dis 9(1):151–164. DOI: 10.14336/AD.2017­.0315.

49. Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J, et al. (2018). SARC-F for sarcopenia screening in community – dwelling older adults. Are 3 items enough? Medicine 97(30): e11726. DOI: 10.1097/ MD.00000000000­11726.

50. Yang M, Lu J, Jiang J, Zeng Y, Tang H (2019). Comparison of four sarcopenia screening tools in nursing home residents. Aging Clin Exp Res 31(10): 1481–1489. DOI: 10.1007/s40520–018–1083-x.

51. Yu SCY, Khow KSF, Jadczak AD, Visvanathan R (2016). Clinical Screening Tools for Sarcopenia and Its Management. Curr Gerontol Geriatr Res 2016: 1–10. DOI: 10.1155/2016/5­978523.